Bio Green Med Solution, Inc. — Director's Dealing 2009

Nov 21, 2009

SEC Form 4/A — Form 4/A

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2008-11-18

Reporting Person: Chiao Judy (V.P., Clin. Dev. & Reg. Aff.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-11-18	Common Stock, $0.001 par value per share	A	25000	—	Acquired	73168	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-11-18	Option	$0.44	A	75000	Acquired	2018-11-18	Common Stock (75000)	Direct

Footnotes

F1: These shares of common stock are represented by restricted stock units, which vest over a four-year period, with one-fourth (1/4) of the restricted stock units granted vesting on November 18, 2009, the first anniversary of the grant date, and the balance of the restricted stock units granted vesting ratably on a monthly basis over the following 36 months.

F2: These securities were issued as part of the Issuer's annual equity compensation to executive officers.

F3: These options are exercisable over a three-year period, with one-third (1/3) of the options granted vesting on November 18, 2009, the first anniversary of the grant date, and the balance of the options granted vesting ratably on a monthly basis over the following 24 months.